Vertex Pharmaceuticals Inc (VRTX)
405.99
+6.13
(+1.53%)
USD |
NASDAQ |
Apr 23, 15:26
Vertex Pharmaceuticals Total Return Level: 399.86 for April 22, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
April 22, 2024 | 399.86 |
April 19, 2024 | 394.28 |
April 18, 2024 | 393.48 |
April 17, 2024 | 393.10 |
April 16, 2024 | 394.17 |
April 15, 2024 | 397.36 |
April 12, 2024 | 396.55 |
April 11, 2024 | 400.23 |
April 10, 2024 | 397.58 |
April 09, 2024 | 404.48 |
April 08, 2024 | 404.22 |
April 05, 2024 | 406.67 |
April 04, 2024 | 404.01 |
April 03, 2024 | 408.81 |
April 02, 2024 | 409.42 |
April 01, 2024 | 420.48 |
March 28, 2024 | 418.01 |
March 27, 2024 | 417.32 |
March 26, 2024 | 418.46 |
March 25, 2024 | 416.03 |
March 22, 2024 | 415.66 |
March 21, 2024 | 415.71 |
March 20, 2024 | 412.11 |
March 19, 2024 | 415.20 |
March 18, 2024 | 411.38 |
Date | Value |
---|---|
March 15, 2024 | 407.69 |
March 14, 2024 | 408.77 |
March 13, 2024 | 413.20 |
March 12, 2024 | 412.45 |
March 11, 2024 | 414.47 |
March 08, 2024 | 413.59 |
March 07, 2024 | 410.54 |
March 06, 2024 | 411.85 |
March 05, 2024 | 415.44 |
March 04, 2024 | 424.03 |
March 01, 2024 | 432.76 |
February 29, 2024 | 420.74 |
February 28, 2024 | 426.97 |
February 27, 2024 | 430.92 |
February 26, 2024 | 433.48 |
February 23, 2024 | 430.11 |
February 22, 2024 | 426.78 |
February 21, 2024 | 419.63 |
February 20, 2024 | 420.64 |
February 16, 2024 | 422.20 |
February 15, 2024 | 426.29 |
February 14, 2024 | 417.88 |
February 13, 2024 | 416.04 |
February 12, 2024 | 418.53 |
February 09, 2024 | 422.91 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
164.61
Minimum
May 13 2019
446.08
Maximum
Jan 30 2024
265.00
Average
255.72
Median
Mar 28 2022
Total Return Level Benchmarks
Amgen Inc | 378.01 |
Eli Lilly and Co | 2105.09 |
Regeneron Pharmaceuticals Inc | 900.16 |
Alpine Immune Sciences Inc | 64.58 |
Moderna Inc | 104.46 |